We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Innova Biosciences Introduces Thunder-Link PLUS
Product News

Innova Biosciences Introduces Thunder-Link PLUS

Innova Biosciences Introduces Thunder-Link PLUS
Product News

Innova Biosciences Introduces Thunder-Link PLUS


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Innova Biosciences Introduces Thunder-Link PLUS"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Innova Biosciences (Innova) has announced the launch of Thunder-Link® PLUS, a new and improved version of the original Thunder-Link kit, enabling even faster and more efficient oligonucleotide conjugation.

The new kit offers all of the advantages of the original Thunder-Link technology, but now also works with antibody fragments and small proteins. Thunder-Link PLUS provides antibody and oligo activation in just 30 minutes, and oligo conjugation in only 1 hour, with no lengthy protocols. The kit enables excellent antibody and oligo recovery, with a robust and flexible clean-up procedure.

Fast, easy and efficient conjugation of oligonucleotides and antibodies has traditionally been a major obstacle when developing assays such as immuno-PCR, proximity extension assays, proximity ligation assays, and electrochemical proximity assays. Thunder-Link and now Thunder-Link PLUS are the easiest to use, fastest, most efficient and most effective oligonucleotide conjugation kits of their kind on the market.

Dr Nick Gee, CEO of Innova Biosciences, commented: “Thunder-Link PLUS has been developed in response to discussions with Innova’s customer base, and represents a continuation of the Company’s drive to be at the forefront of bioconjugation technology and innovation.”

Advertisement